398 filings
Page 8 of 20
8-K
jss4gy9snzizdi
19 Dec 22
Cerevel Therapeutics Announces Positive Results in Emraclidine Ambulatory Blood Pressure Monitoring Trial
8:00am
4
h1nxetw17mi
13 Dec 22
Cerevel Therapeutics / N ANTHONY COLES ownership change
4:44pm
EFFECT
tcel3pdp jxry
21 Nov 22
Notice of effectiveness
12:15am
CORRESP
6wjpo9gq4
16 Nov 22
Correspondence with SEC
12:00am
UPLOAD
z2qdk jdykhx5drc
10 Nov 22
Letter from SEC
12:00am
8-K
lxkec1r mbkpftexnr
8 Nov 22
Cerevel Therapeutics Reports Third Quarter 2022 Financial Results and Business Updates
6:36am
4
r00d9 h7o
3 Nov 22
Cerevel Therapeutics / John Renger ownership change
4:28pm
4
dsa3zx92ry9ywcvo
6 Oct 22
Cerevel Therapeutics / John Renger ownership change
4:59pm
4
s2lfb22vj
14 Sep 22
Cerevel Therapeutics / DEVAL L PATRICK ownership change
5:10pm
4
w07ch fk98y
12 Sep 22
Cerevel Therapeutics / Abraham Ceesay ownership change
4:24pm
4
swm506if8wcjkn fg
24 Aug 22
Cerevel Therapeutics / Abraham Ceesay ownership change
4:05pm
4
p3fxvkre5
18 Aug 22
Cerevel Therapeutics / JOSEPH EDELMAN ownership change
5:10pm
SC 13D/A
59u20u
18 Aug 22
Cerevel Therapeutics / BC Perception ownership change
4:30pm
4
ep8944os0zgh94ctt2qe
17 Aug 22
Cerevel Therapeutics / Abraham Ceesay ownership change
4:15pm
8-K
opzin4r441lzqgpv
16 Aug 22
Entry into a Material Definitive Agreement
4:20pm
8-K
kozwee8y0yr1qx
12 Aug 22
Cerevel Therapeutics Announces Proposed Private Offering of Convertible Senior Notes
5:03pm
424B5
c5c4tc
12 Aug 22
Prospectus supplement for primary offering
4:58pm
4
i9k8xqr ea
12 Aug 22
Cerevel Therapeutics / John Renger ownership change
4:15pm